Aflac
AFL · What the business does, what can go wrong, and how options sellers approach it
What it does
Aflac sells supplemental insurance, which pays cash benefits on top of a person's main health coverage. Its products include cancer, accident, hospital indemnity, disability, dental, vision, life and long-term-care policies. It operates in two main markets: the United States and Japan. Japan has historically been the larger contributor to revenue.
Many policies are sold at the workplace through independent agents and brokers, and the company also reaches customers through digital channels.
How it makes money
Customers pay premiums, and Aflac pays out claims when covered events happen. It earns an underwriting profit when premiums exceed claims and expenses.
The company also earns income by investing the premiums it collects until claims are paid. Because it operates in Japan, results are affected by the yen-to-dollar exchange rate when earnings are translated into dollars.
Why investors own it
Investors often view Aflac as a steady, mature insurer with a recognizable brand and a long record of returning cash to shareholders through dividends and buybacks. Its products are fairly simple. Some investors also like its exposure to Japan as a diversifier.
What can go wrong
- Interest rates and credit losses can hurt the investment portfolio.
- A weaker yen can reduce reported earnings in dollars.
- Claims may run higher than expected.
- Regulatory changes in either country can affect how products are sold or priced.
- Changes in employer benefit buying or in sales channels could slow growth.
- Dividends and buybacks are decided by the board and are not guaranteed.
What to watch
- Sales of new policies in Japan and the U.S.
- Premium persistency (how many customers keep their policies)
- Benefit ratio (claims relative to premiums)
- Yen-to-dollar exchange rate
- Net investment income and credit quality of the portfolio
- Capital deployment: dividend and share repurchase announcements
Options income angle
AFL options are available across many expirations with reasonable activity, though less deep than the most heavily traded names. Spreads can widen on far-out strikes and longer-dated contracts.
Implied volatility tends to be modest and often rises around quarterly earnings, big moves in the yen, interest rate swings and broader financial-sector stress.
One caution for covered call sellers: in-the-money calls can be assigned early before an ex-dividend date, and capping upside means you may miss a sharp rally.
What the latest 10-K says
A plain-English read of the Risk Factors and Management's Discussion in the 10-K for the year ended December 31, 2025, filed February 25, 2026. Figures are as the filing reports them. Read the filing on SEC.gov
The filing in brief
Aflac's 2025 net earnings fell to $3.6 billion, or $6.82 per diluted share, from $5.4 billion, or $9.63 per diluted share, mainly because investment results swung from gains to losses. Adjusted earnings, which strip out investment gains and losses and some one-off items, were $4.0 billion, or $7.49 per diluted share, compared with $4.1 billion, or $7.21. The filing also stresses the company's dependence on Japan, which supplied 53% of adjusted revenues, and the currency and hedging exposure that comes with it.
How the business did
- Total revenues were down 9.3% to $17.2 billion, primarily because of net investment losses of $572 million in 2025 versus net investment gains of $1.3 billion in 2024. The losses included $467 million of net losses from certain derivative and foreign currency gains or losses, and an increase in credit loss allowances of $191 million.
- Aflac Japan's pretax adjusted earnings were $3,440 million versus $3,494 million. Its new annualized premium sales (the yearly value of newly sold policies) rose 18.1% to $498 million, led by a new cancer product, Miraito.
- Aflac U.S. pretax adjusted earnings were essentially flat at $1,421 million versus $1,419 million. Higher incurred claims raised its benefit ratio, the share of premiums paid out as benefits. Corporate and other earned $101 million versus $32 million.
- Cash flow from operating activities was $2,555 million versus $2,707 million. The company repurchased $3.5 billion, or 33.0 million, of its common shares and returned $4.7 billion to shareholders through buybacks and dividends. Dividends paid were $2.32 per share, up 16.0%.
- Management flagged a June 2025 cyber incident. Personal information tied to approximately 22.65 million individuals was involved. Management does not believe it is reasonably likely to have a material impact on results.
Risks specific to this company
- Japan concentration: Aflac Japan was 76% of total assets at December 31, 2025. The company holds large amounts of Japan Government Bonds, and its largest unrealized loss position is Japan National Government at $(4,184) million.
- Yen and hedging: Results are translated from yen into dollars, so a weaker yen shrinks reported results. Aflac Japan holds U.S. dollar investments that are partly unhedged, and a sharp yen strengthening could strain cash at the Parent Company through collateral and settlement demands.
- Commercial real estate: Some transitional real estate loans and commercial mortgage loans, including office-backed ones, are in default. In 2025 the company completed foreclosures on loans with an amortized cost of $257 million and recognized a net loss of $10 million.
- Dividend capacity and capital ratios: The Parent Company relies on subsidiary dividends. Aflac Japan's solvency margin ratio (SMR), a regulatory capital measure, fell to 995% from 1,221%, and Aflac U.S.'s combined risk-based capital (RBC) ratio fell to 570% from 677%.
- Cyber incident fallout: Management says it may still face costs from credit monitoring, potential litigation, government investigations and enforcement actions, and how much insurance will cover is still being assessed.
- Agent classification: A majority of the U.S. sales force are independent agents. A ruling or law change treating them as employees could bring fines, legal costs and changes to the U.S. business model.
What management is watching
- 2026 ratios: Aflac Japan benefit ratio of 60% to 63% and expense ratio of 20% to 23%. Aflac U.S. benefit ratio of 48% to 52% and expense ratio of 36% to 39%, with the U.S. benefit ratio pushed up by growth in life, disability, and dental and vision products.
- Growth plans: Preserving solid pretax profit margins while raising sales through promotion of products launched in 2025 in Japan and growth initiatives in both segments.
- Capital and dividends: A 5.2% increase in the quarterly dividend takes effect in the first quarter of 2026. Targets are an economic solvency ratio (ESR) of 170% to 230% for Aflac Japan and a combined RBC range of 350% to 450% for Aflac U.S. The first official ESR report under Japan's new regime is due as of March 31, 2026.
- Technology and ventures: Spending on technology upgrades and digital capabilities continues. Of the $400 million committed to Aflac Ventures, approximately $297 million has been deployed.
- Measures cited: Adjusted earnings, adjusted book value excluding foreign currency remeasurement, and adjusted return on equity excluding foreign currency remeasurement, which was 17.6%.
What the latest 10-Q says
A plain-English read of Management's Discussion (and any new or changed risk factors) in the 10-Q for the quarter ended September 30, 2026, filed November 5, 2026. Figures are as the filing reports them. Read the filing on SEC.gov
The quarter in brief
Aflac's third-quarter net earnings fell to $303 million, or $.61 per diluted share, from $1.6 billion, or $3.08 per diluted share, a year earlier. The drop came mainly from net investment losses of $1.1 billion, which the filing ties largely to a strategic repositioning of the investment portfolio. Adjusted earnings, which leave out investment gains and losses, were $1.2 billion, or $2.43 per diluted share, compared with $1.3 billion, or $2.49.
How the business did
- Headline results: Total revenues were $3.3 billion, compared with $4.7 billion a year earlier. For the first nine months, net earnings were $2.1 billion, or $4.24 per diluted share, compared with $2.3 billion, or $4.21. Adjusted earnings per diluted share were $5.92 in both periods.
- Aflac Japan: Pretax adjusted earnings were $961 million, compared with $1,216 million. Management attributes the decline mainly to smaller reserve remeasurement gains. These are gains from the annual update of the assumptions used to value future policy obligations. New sales on a yen basis fell, partly because marketing was paused after a June 2026 cyber incident in Japan. All normal marketing had resumed by quarter end.
- Aflac U.S.: Pretax adjusted earnings were $493 million, compared with $375 million. Premium growth, larger reserve remeasurement gains and a one-time technology expense in the prior-year period drove the change.
- Yen effect: The average yen/dollar rate was 158.49, or 6.8% weaker than a year earlier, which reduced adjusted earnings per diluted share by $.03.
- Unusual items and capital return: The company recorded a $51 million valuation allowance against deferred tax assets tied to tax capital loss carryforwards. The quarter's effective tax rate was 39.6%, compared with 17.8%. Over nine months the company repurchased $2.8 billion, or 24.3 million shares, with 90.0 million shares still authorized. Operating cash flow was $2,277 million, compared with $2,240 million.
What management is watching
- Benefit ratios: Management now expects Aflac Japan's full-year benefit ratio (claims and benefits as a share of premiums) to be slightly below the range of 60% to 63%. It expects Aflac U.S.'s to be below the range of 48% to 52%.
- Japan cyber incident: The company says the potential loss cannot be reasonably estimated, though it does not believe the incident is reasonably likely to have a material impact on financial condition or results. Higher costs tied to it already appear in Aflac Japan's expenses. The company also says it cannot reasonably estimate the potential loss from the June 2025 U.S. cyber incident.
- Japan solvency and hedging: Aflac Japan's Economic Solvency Ratio is sensitive to interest rates, credit spreads and exchange rates. Among the alternatives the company is evaluating are lower subsidiary dividends to the parent and parent capital contributions. Subsidiary dividends to the parent were $2,088 million over nine months, compared with $3,058 million.
- Measures management points to: Adjusted earnings, adjusted book value excluding foreign currency remeasurement ($40.73 per share, compared with $42.66 at December 31, 2025), and adjusted return on equity excluding foreign currency remeasurement (23.7% for the quarter). The fourth-quarter dividend was declared at $.61 per share, up 5.2%.
Follow AFL in Kortex
The Kortex app shows AFL's price, options chain and IV rank, and answers your questions from live market data and SEC filings.
Free to download.
Learn the strategies
More stock briefs
For education only, not financial advice. Options involve risk and are not suitable for every investor.